Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if AzaSite Plus is effective and safe for the treatment of blepharoconjunctivitis compared to AzaSite alone and Dexamethasone alone.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: InSite Vision; Sun Pharma Global FZE
• Treatments: Azithromycin; BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate

Criteria

Inclusion Criteria:

• Have a clinical diagnosis of blepharoconjunctivitis

• Must be willing to discontinue contact lens wear for the duration of the study

• Additional inclusion criteria also apply.

Exclusion Criteria:

• Have known sensitivity or poor tolerance to any component of the study medications.

• Have any clinically significant cardiovascular disorders

• Have any history of liver or kidney disease resulting in persisting dysfunction

• Have prior (within 30 days of beginning study treatment) or anticipated concurrent use of an investigational drug or device.

• Additional exclusion criteria also apply.